Keymed Biosciences Inc. carries a market capitalization of 25.59B, placing it among publicly traded companies globally.
| Market Cap | 25.59B |
| Enterprise Value | N/A |
Keymed Biosciences Inc.'s stock has gained approximately 90.04376% over the past 52 weeks. The 50-day moving average sits at 65.73, while the 200-day moving average is 61.67.
| Beta (5Y) | N/A |
| 52-Week Price Change | 90.04376% |
| 50-Day Moving Average | 65.73 |
| 200-Day Moving Average | 61.67 |
| Average Volume (20 Days) | N/A |